Pfizer to acquire Medivation for $14bn

22-08-2016

Pfizer to acquire Medivation for $14bn

Photo: Gajus / Shutterstock.com

Pfizer has unveiled plans to acquire US based biopharmaceutical company Medivation for approximately $14 billion.


Pfizer, Medivation, cancer drug, M&A,

LSIPR